CHAC1
CHAC1 (ChaC glutathione specific gamma-glutamylcyclotransferase 1, also known as MGC4504) is a cytosolic enzyme that cleaves glutathione into 5-oxo-L-proline and a Cys-Gly dipeptide. It links glutathione turnover to apoptosis, the unfolded protein response and Notch signalling. Browse Assay Genie's current range of CHAC1 research reagents below, or read on for the biology behind the target.
CHAC1 catalyses the cleavage of glutathione into 5-oxo-L-proline and a Cys-Gly dipeptide. It acts specifically on glutathione and not on other gamma-glutamyl peptides. Because glutathione depletion is an important factor in the initiation and execution of apoptosis, this activity places CHAC1 at the interface of redox balance and cell death. NCBI Gene also notes a possible role in regulating glutathione levels and oxidative balance in the cell.
CHAC1 acts as a pro-apoptotic component of the unfolded protein response, where it mediates the pro-apoptotic effects of the ATF4-ATF3-DDIT3/CHOP cascade. It also negatively regulates Notch signalling in embryonic neurogenesis. By inhibiting Notch cleavage by furin, it keeps Notch in an immature, inactive form and so promotes neurogenesis in embryos. NCBI Gene describes this as deglycination of the Notch receptor, which prevents receptor maturation. UniProt locates the protein in the cytosol and the trans-Golgi network.
The CHAC1 gene encodes a member of the gamma-glutamylcyclotransferase family, ChaC subfamily, and HGNC places it in the carbon-nitrogen lyases gene group. Its previous name was ChaC, cation transport regulator homolog 1 (E. coli). Mouse and rat both carry a Chac1 ortholog. According to NCBI Gene, elevated CHAC1 expression may indicate an increased risk of cancer recurrence among breast and ovarian cancer patients, which makes the CHAC1 gene of interest in cancer research.
CHAC1 mediates the pro-apoptotic effects of the ATF4-ATF3-DDIT3/CHOP cascade, making it a useful readout of stress-induced cell death signalling.
CHAC1 degrades glutathione specifically, so it is studied in relation to glutathione levels, oxidative balance and apoptosis.
CHAC1 inhibits furin cleavage of Notch, keeping it inactive and promoting neurogenesis in the embryo.
Elevated CHAC1 expression may indicate increased risk of recurrence among breast and ovarian cancer patients.
CHAC1 is a gamma-glutamylcyclotransferase that cleaves glutathione into 5-oxo-L-proline and a Cys-Gly dipeptide, acting only on glutathione. It also promotes apoptosis as part of the unfolded protein response and inhibits Notch signalling during embryonic neurogenesis.
CHAC1 is the HGNC symbol for ChaC glutathione specific gamma-glutamylcyclotransferase 1. UniProt calls it glutathione-specific gamma-glutamylcyclotransferase 1. Earlier designations include MGC4504 and the name ChaC, cation transport regulator homolog 1 (E. coli). Its enzyme classification is EC 4.3.2.7.
Mouse and rat each have a Chac1 ortholog, so the protein can be studied in common model species; check the datasheet of any product for its validated reactivity. NCBI Gene reports that elevated CHAC1 expression may indicate higher cancer recurrence risk in breast and ovarian cancer patients.
Unfolded protein response regulators, Notch pathway components and other targets linked to glutathione metabolism and apoptosis.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q9BUX1; product specifications from Assay Genie datasheets.